Express News | Radius Pharmaceuticals Expands Abaloparatide Licensing Agreement With Theramex, Granting Exclusive Commercialization Rights For ELADYNOS In Mexico, Canada, South Africa, Israel, And Russia, Along With Additional Unpartnered Regions; Radius To Receive...
Radius Pharmaceuticals Expands Abaloparatide Licensing Agreement With Theramex Granting Additional Commercialization Rights Including Mexico, Canada, South Africa, Israel, and Russia
Steel Stocks Rise as Goldman Takes Positive View; Likes Cliffs, Commercial Metals, Nucor
Radius Recycling Initiated at Neutral by Goldman Sachs
Express News | Goldman Sachs Initiates Coverage On Radius Recycling With Neutral Rating, Announces Price Target of $22
Radius Recycling Analyst Ratings
